logo
Plus   Neg
Share
Email

BNY Mellon Q4 Profit Halves, But Results Top Estimates - Quick Facts

Bank of New York Mellon Corp. (BK) reported Wednesday that net income applicable to common shareholders for the fourth quarter halved to $702 million or $0.79 per share from $1.39 billion or $1.52 per share in the prior-year quarter.

Excluding items, adjusted net income for the quarter were $861 million or $0.96 per share, compared to $931 million or $1.01 per share in the year-ago quarter.

Total revenue for the quarter decreased 20 percent to $3.84 billion from $4.78 billion in the same quarter last year.

On average, analysts polled by Thomson Reuters expected the company to report earnings of $0.91 per share on revenue of $3.83 billion for the quarter. Analysts' estimates typically exclude certain special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration said that it will rapidly work toward finalization and issuance of an emergency use authorization of Johnson & Johnson's (JNJ) single-shot COVID-19 vaccine candidate. Billionaire Warren Buffett's Berkshire Hathaway Inc. (BRK.A, BRK.B) reported that its fourth-quarter net earnings attributable to shareholders rose 23 percent to $35.84 billion from last year's $29.16 billion, with earnings per share improving to $23,015 per Class A share from $17,909 per Class A share in the prior year. Walmart Inc. has launched a nationwide drive to boost COVID-19 vaccination rates by reaching out to more residents in vulnerable communities. The retail giant will organize a series of community events at 43 locations in 18 states to administer the COVID-19 vaccine. Walmart said it plans to continue these new events over the next several weeks as vaccine allocations allow.
Follow RTT